Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01689558
What this trial is testing

Recombine Endostatin With Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation in Advanced Nasopharynx Cancer

Who this might be right for
1、Enough Cases2、Elekta Precise 1343 Digital Control Electron Linear AcceleratorCan Undertake Nasopharyngeal Carcinoma Specimens in the Materia，+1 more
Jin Feng 60
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Large-scale testing (Phase 3)Study completedNCT05523323
What this trial is testing

Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 112
Testing effectiveness (Phase 2)Looking for participantsNCT07000253
What this trial is testing

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

Who this might be right for
Esophageal CancerGastric (Stomach) CancerGastric Adenocarcinoma+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 290
Testing effectiveness (Phase 2)Ended earlyNCT00872404
What this trial is testing

CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Who this might be right for
Head and Neck Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 37
Testing effectiveness (Phase 2)Study completedNCT00116909
What this trial is testing

OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Who this might be right for
Locally Recurrent or Metastatic Cancer of the Head and NeckMust Have Failed First-Line Therapy
OSI Pharmaceuticals 85
Testing effectiveness (Phase 2)Looking for participantsNCT06445972
What this trial is testing

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

Who this might be right for
Gastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more
Merck Sharp & Dohme LLC 210
Not applicableUnknownNCT05349799
What this trial is testing

TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines

Who this might be right for
Skin AgingFine Lines of the Face and Neck
Teoxane SA 67
Not applicableLooking for participantsNCT06478485
What this trial is testing

Laminoplasty for Multilevel Cervical Spondylotic Myelopathy Guided by Modified K-line and Modified SC-line in MRI

Who this might be right for
Modified K-line and Modified SC-line in MRI
Affiliated 2 Hospital of Nantong University 300
Large-scale testing (Phase 3)WithdrawnNCT04129320
What this trial is testing

Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
MacroGenics
Testing effectiveness (Phase 2)Study completedNCT02273713
What this trial is testing

The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)

Who this might be right for
Esophageal CancerToxicity
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 154
Large-scale testing (Phase 3)Active Not RecruitingNCT04534205
What this trial is testing

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

Who this might be right for
Unresectable Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck CancerRecurrent Head and Neck Cancer
BioNTech SE 358
Testing effectiveness (Phase 2)Study completedNCT00836277
What this trial is testing

Phase II Study of Irinotecan and Panitumumab

Who this might be right for
Esophageal Cancer
Weijing Sun, MD, FACP 24
Not applicableLooking for participantsNCT06116019
What this trial is testing

Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)

Who this might be right for
Prostate CancerHead and Neck CancerNSCLC+6 more
Charite University, Berlin, Germany 649
Large-scale testing (Phase 3)UnknownNCT05446883
What this trial is testing

QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer

Who this might be right for
METASTATIC CERVICAL CANCER
Qilu Pharmaceutical Co., Ltd. 498
Large-scale testing (Phase 3)Looking for participantsNCT07264075
What this trial is testing

Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Who this might be right for
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Groupe Oncologie Radiotherapie Tete et Cou 780
Large-scale testing (Phase 3)Looking for participantsNCT06699212
What this trial is testing

ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Rakuten Medical, Inc. 412
Testing effectiveness (Phase 2)Study completedNCT01605305
What this trial is testing

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 60
Testing effectiveness (Phase 2)Study completedNCT05673577
What this trial is testing

Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Fudan University 41
Testing effectiveness (Phase 2)Study completedNCT04646005
What this trial is testing

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Who this might be right for
Cervical Cancer
Regeneron Pharmaceuticals 113
Next Page